Infertility affects nearly 15 per cent of all couples in reproductive age group. Female infertility has a major role in almost 50 per cent of the infertile couple population, endometrium being one of the concerns such as endometrium hyperproliferation, including endometrial cancer, endometrial hyperplasia, endometriosis, endometrial infection such as tuberculosis, thin endometrium and the female is incapable of carrying a pregnancy to term. Implantation failure of the blastocyst is also one of the important issues[@ref1]. Endometrium plays a central role in the maintenance of pregnancy with the help of many signalling molecules[@ref2].

Human endometrium has a remarkable regenerative capacity[@ref3], growing from 0.5 to 1 mm following menstruation to 5-7 mm in thickness in average menstrual cycle[@ref4], and is characterized by cyclic processes of cellular proliferation, differentiation and shedding. The endometrial thickness between 7 and 14 mm with a triple-line configuration is considered favorable for embryo implantation[@ref2].

Prianishnikov in 1978[@ref5] has brought the concept that endometrial regeneration is mediated by stem cells located in the basalis endometrium, rather than the functionalis or myometrium. The characteristics of the endometrium are suggestive of the presence of an adult stem/progenitor cell population, which is responsible for the expressed regenerative capacity of this tissue[@ref6]. Endometrial stem cells are the specialized cells which modulate endometrium for self-renewal, proliferation, differentiation and shedding off during the monthly menstrual cycle[@ref3]. These cells also prepare the endometrium to receive the fertilized egg by hyperproliferation and angiogenesis of endometrium. Many groups have illustrated the concept of endometrial stromal/mesenchymal stem cells which reside in basalis layer of the endometrium. There are several markers expressed by the endometrial stromal cells such as platelet-derived growth factor receptor-beta, CD9, CD146, CD90, CD73, CD105, CD44 and CD29[@ref7][@ref8][@ref9][@ref10][@ref11][@ref12].

Whether these endometrial stromal/mesenchymal stem cells play any role in the establishment or maintenance of the pregnancy is not known. CD9 and CD146 are the two markers that have been studied in mice and shown to be associated with implantation[@ref13]. CD9, a marker of the tetraspanin family, is a 24-27 kDa cell surface protein with four predicted transmembrane domains[@ref13]. CD9 is recognized as a motility-related protein 1 that plays a key role in sperm-egg fusion. CD9-deficient eggs fail to fuse with sperm[@ref14]. CD9 is associated with integrin adhesion receptors and controls integrin-dependent cell migration and invasion during blastocyst implantation[@ref12]. In an experimental study, CD9-deficient endometrium in mouse failed to implant compared to the CD9-positive endometrium[@ref13]. CD9 is associated with blastocyst implantation by producing matrix metalloproteinase-2[@ref9].

CD146 is a cell adhesion molecule (CAM) which belongs to the immunoglobulin (Ig) superfamily. CAMs are proteins located on the cell surface involved in the process of cell adhesion through binding with other cells or with the extracellular matrix (ECM)[@ref15]. There have been reports stating the importance of CD146 to be involved in trophoblast invasion during pregnancy establishment in mice[@ref15][@ref16]. CD146 is shown to be selectively expressed by invasive trophoblasts, whereas non-invasive trophoblast has no expression of CD146[@ref15]. CD146 is expressed in receptive maternal uterus and invasive embryonic trophoblasts but found absent in non-pregnant uterus in mouse. Blocking the function of CD146 *in vivo* and *in vitro* inhibits blastocyst attachment and trophoblastic invasion, leading to pregnancy failure[@ref15].

In some studies luminal epithelium of the endometrium has been studied for infertility[@ref17][@ref18], but there are no reports on role of endometrial stromal cells in infertility. Therefore, the present study was conducted to examine the human endometrial stromal cell obtained from both fertile and infertile women for the presence of adhesion molecules CD9 and CD146 to assess whether dysregulation in these molecules could be a factor for infertility.

Material & Methods {#sec1-2}
==================

This study was carried out from 2009 to 2012 for the period of three years. Patients were recruited for this study from Jaslok Hospital and Inkus Infertility Clinic by convenient sampling. Enrolment period of the study was 19 months. The study protocol was approved by the Ethics Committee of Jaslok Hospital and Research Centre and informed written consent was obtained from each patient. The inclusion criteria were the women who had regular menstrual cycle, aged between 21 and 40 yr and had not taken any steroid hormones before three months of endometrial biopsy. The exclusion criteria were cases of pregnancy, male factor infertility and women with polycystic ovarian syndrome, endometriosis, abnormal uterine bleeding, endometrial hyperplasia and body mass index (BMI) of ≥30 kg/m^2^. Fertile group women had proven fertility (natural conception with full-term delivery and no history of missed abortion) and infertile group women had no conception and no history of missed abortion before the recruitment. Based on the above criteria, cases and controls were matched. A portion of each endometrial specimen obtained was examined histologically.

Human endometrial biopsy samples were collected from 100 women (n=100). Infertile group samples were collected from females undergoing diagnostic hysteroscopy (n=50). Basal characteristics of the study groups are shown in [Table I](#T1){ref-type="table"}. Mean age of infertile group women was 29.62±4.08 yr (range 21-40 yr), and of fertile group women was 34.12±6.6 yr (range 22-37 yr). Fertile group samples were collected from females undergoing tubal ligation (n=50). All the samples were collected in the secretory phase of menstrual cycle.
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*Collection of endometrial samples*: Endometrium sample was collected in bench medium containing HEPES-buffered Dulbecco modified Eagle medium/Hams F-12 (DMEM/F-12; Gibco Invitrogen, USA), 1 per cent antibiotic-antimycotic solution (Gibco Invitrogen, USA) and 5 per cent foetal bovine serum (Gibco Invitrogen).

*Primary endometrial stromal cell culture*: After the collection of the endometrial samples, the samples were brought to the laboratory at 4°C. Endometrial tissue was dissected and minced to 1-2 mm[@ref3] pieces using scissors. Minced tissue was digested with DMEM containing 0.1 per cent collagenase type IV (Sigma, USA) in a humidified 5 per cent CO~2~/95 per cent air atmosphere at 37°C for one hour. The cell suspension was filtered through a 40 μm cell strainer (BD Falcon, USA) to remove mucus and undigested tissue[@ref6]. The cell filtrates were centrifuged at 250 ×*g* for five minutes and the cell pellet was resuspended in culture medium containing DMEM/F-12, 1 per cent antibiotic-antimycotic solutions (Gibco Invitrogen) and 1 per cent L-glutamine supplemented with 15 per cent heat-inactivated sterile-filtered foetal bovine serum.

The cells were plated in a T25 cm^2^ tissue culture flask (Corning, USA). The cells were cultured overnight in a humidified 5 per cent CO~2~/95 per cent air atmosphere at 37°C and non-adherent cells were discarded. The culture medium was replaced every 48 h. Primary cell lines were established for all the 100 patients' endometrial samples[@ref5].

*Flow cytometric analysis*: Immunophenotyping of the all 100 cultured endometrial stromal cells was performed after fifth passage by means of flow cytometry. Cells were washed with Dulbecco\'s phosphate-buffered saline (PBS) and harvested using acutase (Invitrogen); cells were pelleted to one ml of cell suspension, concentration 1×10^6^/ml. Staining was performed with antibodies against CD9 (PerCP) from Becton Dickinson (BD, USA), primary CD146 monoclonal antibody from Millipore (USA) and FITC-conjugated goat anti-mouse IgM secondary antibody from Millipore. Cells were incubated in primary antibody (10 μl in case of conjugated and 1:100 for unconjugated) for 30 min at room temperature after the incubation cells were washed with FACS solution (0.1% bovine serum albumin, 0.1% sodium azide in PBS) and incubated in 10 μl secondary antibody (1:1000) in the dark at 2-8°C for 30 min. At the end, the cells were fixed in 1 per cent paraformaldehyde and re-suspended in FACS solution[@ref5]. The specific fluorescent labelling was analyzed at FACSCalibur flow cytometer (BD) using the built-in CellQuest Pro software (Version 5.1); 10,000 events were analyzed for each sample.

*Real-time polymerase chain reaction (PCR)*: Total RNA was harvested from 100 cultured endometrial stromal cells, using the TRIzol™ reagent (Invitrogen) and treated with DNase I (Bangalore Genei Pvt. Ltd., Bengaluru).First-strand cDNA was synthesized using the Clontech Advantage RT Kit (Clontech BD Biosciences, USA) using of Moloney murine leukemia virus (MMLV) reverse transcriptase.

CD9 and CD146 expression levels were studied in fertile and infertile group in relation to 18S rRNA (housekeeping gene) on the R Corbett Research Real-Time PCR system (Rotor-Gene) using SYBR green chemistry (Bio-Rad, USA). The amplification conditions, primer concentration and annealing temperature were standardized to obtain single peak melt curve. The homogeneity of the PCR amplicons was verified by running the products on 1.5 per cent agarose gels and also by studying the melt curve. All PCR amplifications were carried out in duplicate. Mean cycle threshold (Ct) values generated in each experiment using the rotor-gene analysis software (Rotor-Gene Q, Qiagen, Germany) were used to calculate fold change. The relative gene expression ratios were calculated manually by the 2^−ΔΔCt^ method[@ref19].

PCR primers were designed using Primer3 Input (v.0.4.0) *<http://bioinfo.ut.ee/primer3-0.4.0/>*. The following forward (F) and reverse (R) primers were used: for CD9 F: 5' TTG GAC TAT GGC TCC GAT TC 3' and R: 3' GGC GAA TAT CAC CAA GAG GA 5'; for CD146 F: 5' CCA AGG CAA CCT CAG CCA TGT C 3' and R: 3'CTC GAC TCC ACA GTC TGG GAC G 5' and for 18S F:5'GGA GAG GGA GCC TGA GAA AC 3' and R: 3'CCT CCA ATG GAT CCT CGT TA 5'.

*Statistical analysis*: Infertile females and fertile females were compared for the difference in baseline characteristics using the Student\'s *t* test. Differences between fertile and infertile groups for the CD9 and CD146 markers were assessed using the non-parametric Mann-Whitney U-test. Logistic regression analysis was performed for the confounding factors such as age, BMI and menstrual pattern to explore the interaction of infertility and fertility with CD9 and CD146 expression. Univariate logistic regression was performed for all the factors; factors giving *P*\<0.1 were further analyzed by multivariate logistic regression analysis. By modelling each parameter, the fertility prediction equation was accessed. The data were analyzed using Statistical Package for the Social Sciences (SPSS) software (version 20.0; SPSS Inc., Chicago, IL, USA).

Results {#sec1-3}
=======

Basal characteristics of the study groups are shown in [Table I](#T1){ref-type="table"}. Mean age of infertile group women was 29.62±4.08 yr, age range 21-40 yr, and of the fertile group women was 34.12±6.6 yr, age range 22-37 yr (*P*\<0.001). Mean BMI kg/m^2^ of the infertile group was 19.69±5.55 and of the fertile group was 5.02±9.54 (*P*\<0.01) whereas mean of menstrual pattern in the infertile group was 28.62±1.14 and in the fertile group showed 28.9±1.26. Age and BMI were found to be significant in both the groups.

*Endometrial stromal cells (primary cell lines)*: Endometrial stromal cell lines (primary cell lines) were established from 100 endometrial samples including fertile and fertile patients. Morphologically, there was no difference in the endometrial stromal cells of both the groups. Endometrial stromal cells were stable in culture and multiplied every 19-20 h.

After 24 h of culture both epithelial and stromal cells were observed. Passage one onwards, fibroblast-like stromal cells were the only cells growing in the culture. After 10-14 days, these cells formed a single colony at the beginning and then merged as a monolayer. These cells are also called as endometrial stromal/mesenchymal stem cells. After the third passage, the spindle-like stromal cells were the only cell type found in the culture. Morphologically, no significant difference was observed between the endometrial stromal cells of fertile samples and infertile samples.

*Expression of CD9 and (CD146) by flow cytometry*: Differential expression of CD9 and CD146 was observed in fertile and infertile endometrial stromal cells by flow cytometry (n=100). Significantly (*P*\<0.05) lower levels of adhesion molecule CD9 were observed in the infertile endometrial stromal cells as compared to fertile endometrial stromal cells (Figs. [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}).
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![Flow cytometric expression analysis of CD9 and CD146 levels in the fertile and infertile endometrial stromal cells showing significant lower expression in infertile group having (*P*\<0.01) for CD9 and (*P*\<0.01) for CD146 (height of bar represents median and error bar indicates standard deviation).](IJMR-147-552-g003){#F2}

Strong expression of CD146 adhesion molecule was detected in fertile females' endometrial stromal cells ([Fig. 3A](#F3){ref-type="fig"}) and the infertile group showed less expression of CD146 ([Fig. 3B](#F3){ref-type="fig"}). Results of flow cytometry showed significantly (*P*\<0.01) lower levels of CD146 in the infertile endometrial stromal cells compared to fertile endometrial stromal cells ([Fig. 2](#F2){ref-type="fig"}).

![Representative scatter plot showing flow cytometric expression of CD146 in cultured endometrial stromal cells of fertile group (**A**) and infertile group (**B**).](IJMR-147-552-g004){#F3}

*Differential expression of CD9 and CD146 by real-time PCR*: Endometrial stromal cells of the fertile and infertile females (n=100) were subjected to real-time PCR and gene expression results showed significantly (*P*\<0.001) lower expression of both CD9 and CD146 in the infertile endometrial stromal cells compared to fertile endometrial stromal cells ([Fig. 4](#F4){ref-type="fig"}).
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*Association of CD9 and CD146 with age, BMI and menstrual pattern*: Multiple logistic regression was done for the variables that gave *P*\<0.1 in univariate regression analysis; age and BMI had a *P*=0.001 and *P*=0.0033, respectively, whereas menstrual pattern showed *P*=0.2424. When univariate logistic regression of CD9 was performed in the fertile and infertile group, the model showed the *R*^2^ value of 0.0444 ([Table II](#T2){ref-type="table"}) which was a poor predictor of fertility. When the age and BMI were included in the model, the *R*^2^ value increased to 0.2175 which was a better predictive probability of fertility in females ([Table III](#T3){ref-type="table"}). Similarly, in case of CD146 in univariate logistic regression, the model showed *R*^2^ value of 0.0562 ([Table IV](#T4){ref-type="table"}) which was a poor predictor of fertility. When age and BMI were added to the model, the *R*^2^ value increased to 0.2047 which was a better predictive probability of fertility in females ([Table V](#T5){ref-type="table"}).
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Multiple logistic regression analysis in group CD9 with age and body mass index
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Logistic group univariate analysis for CD146
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Multiple logistic regression analysis in group CD146 with age and body mass index
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Discussion {#sec1-4}
==========

In the current study, the population of endometrial stromal cells isolated from human endometrium of fertile and infertile females was compared. Morphologically, there was no significant difference in the endometrial stromal cells obtained from fertile and infertile patients. The expression of CD9 and CD146 was found to be significantly associated with fertility. The endometrial stromal cell expression of CD9 and CD146 has been reported to be associated with infertility related to the endometrium[@ref12][@ref16].

Our results showed that the CD9 and CD146 expression was significantly lower in the infertile female\'s endometrial stromal cells in culture compared to fertile females. CD9 and CD146 markers are found to be significant in the fertile and infertile groups, and their expression influences the outcome of the patient being fertile. Age, BMI and menstrual pattern are confounding factors that are known to affect the fertility. Infertility rate in females increases with increased BMI and obesity[@ref20]. Fertility decreases with increase in age[@ref21]. When taken into univariate logistic analysis, CD9 was able to explain only 0.04 per cent (pseudo-*R*^2^=0.0444) and CD146 (pseudo-*R*^2^=0.0563) 0.05 per cent in predicting the outcome. CD9 could predict the outcome of fertility by 0.04 per cent; when age and BMI were included into the equation, the probability of predicting fertility increased to 0.21 per cent.

With an age of 30 yr and BMI to be 21 kg/m^2^ which was mean of the study population, if CD9 expression was 100, that means it will have predictive value was 0.51.

In CD146 group it turned out to be marginally insignificant including age and BMI, hence, probably, increasing the sample size or adding more variables to the study will help to better predict the outcome of the patient being fertile.

Several reports showed that adhesion molecules play a vital role in embryo attachment and trophoblasts invasion during the process of implantation. CD9 and CD146 have been previously reported as the important adhesion molecules which take part in the adhesion and invasion of blastocyst[@ref13][@ref15][@ref16].

Liu *et al*[@ref16] showed the effect of CD146 antibody *in vitro* and *in vivo* during blastocyst attachment and trophoblast invasion. They found out that CD146 expression was absent in the uteri of non-pregnant mice and was found to be upregulated during the implantation window.

CD9 has been reported to associate with several integrins in a number of migration, adhesion and fusion systems, including a3, a5, 6 or b1 subunits[@ref21]. A study in mice showed that blocking of CD9 antibody *in vivo* and *in vitro* inhibited implantation of blastocyst and invasion of trophoblast, resulting in failure of pregnancy[@ref15].

Decidualization is an important event in the establishment of pregnancy. In humans, decidualization is initiated by endometrial stromal cells which occur in the secretory phase of menstrual cycle independently of pregnancy[@ref3]. Decidualizing endometrial stromal cells prepare the endometrium for embryo recognition and selection by means of biological functions such as cell adhesion, signal transduction, cell proliferation, ECM organization, cell differentiation and apoptosis[@ref22][@ref23]. Decidualization is basically a differentiation of endometrial stromal cells into secretory epithelioid-like decidual cells under the influence of progesterone[@ref24][@ref25].

In conclusion, our study demonstrates that CD9 and CD146 adhesion molecules in female\'s endometrial stromal cells have the possible role in the decidualization and attachment to the embryo. In future, it would be interesting to see the expression of these molecules on blastocyst as well as on decidual cells to draw a conclusion on the role of these molecules in infertility. However, based on the findings of this study it can be suggested that, intrauterine release of adhesion promoting factors may improve implantation. More studies need to be done to see if the administration of CD9 and CD146-positive cells (autologous bone marrow) in the endometrium improves implantation in infertile females.
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